(Q38901466)

7 September 2017

title

EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model (English)

1 reference

7 September 2017

Dandan Liang

1

1 reference

7 September 2017

Peng Zhong

2

1 reference

7 September 2017

Jie Hu

3

1 reference

7 September 2017

Feng Lin

4

1 reference

7 September 2017

Yuanyuan Qian

5

1 reference

7 September 2017

Zheng Xu

6

1 reference

7 September 2017

Jingying Wang

7

1 reference

7 September 2017

Chunlai Zeng

8

1 reference

7 September 2017

Xiaokun Li

9

1 reference

7 September 2017

Guang Liang

10

1 reference

7 September 2017

publication date

7 March 2015

1 reference

Journal of Molecular and Cellular Cardiology

7 September 2017

published in

1 reference

7 September 2017

volume

82

1 reference

7 September 2017

page(s)

63-74

1 reference

Mechanisms of diabetic complications.

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Molecular mechanisms of diabetic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

ErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Activation of EGFR/ERBB2 via pathways involving ERK1/2, P38 MAPK, AKT and FOXO enhances recovery of diabetic hearts from ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

And what about epidermal growth factor (EGF) as the bridge between survivin and cardiac remodelling?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

The epidermal growth factor receptor: a missing link between endoplasmic reticulum stress and diabetic complications?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Metallothionein alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of Ca2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Epidermal growth factor receptor inhibition slows progression of diabetic nephropathy in association with a decrease in endoplasmic reticulum stress and an increase in autophagy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signalling in mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Epidermal growth factor receptor transactivation is regulated by glucose in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Mitochondrial genetics: a paradigm for aging and degenerative diseases?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Decreased complex II respiration and HNE-modified SDH subunit in diabetic heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Oxidative stress, diabetes, and diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

A disintegrin and metalloprotease 17 mediates neointimal hyperplasia in vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

EGFR signaling promotes TGFβ-dependent renal fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Integrin alpha1beta1 controls reactive oxygen species synthesis by negatively regulating epidermal growth factor receptor-mediated Rac activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Epidermal growth factor stimulates nuclear factor-κB activation and heme oxygenase-1 expression via c-Src, NADPH oxidase, PI3K, and Akt in human colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

The signaling pathway for aldosterone-induced mitochondrial production of superoxide anion in the myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Naringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-κB activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human airway epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Cardiotoxicity of calmidazolium chloride is attributed to calcium aggravation, oxidative and nitrosative stress, and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.02.029

10.1016/J.YJMCC.2015.02.029

7 January 2021

Identifiers

DOI

1 reference

7 September 2017

1 reference